Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5582/ddt.2020.01015 http://scihub22266oqcxt.onion/10.5582/ddt.2020.01015 32378648!ä!32378648 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Ther 2020 ; 14 (2): 73-76 Nephropedia Template TP {{tp|p=32378648|t=2020. Rapid review for the anti-coronavirus effect of remdesivir |pdf=|usr=}}{{32378648}} gab.com Text Rapid review for the anti-coronavirus effect of remdesivir JO: Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32378648 #FOAvip The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification. Twit Text FOAVip Rapid review for the anti-coronavirus effect of remdesivir ????Drug Discov Ther http://www.kidney.de/pget.php?&tw=1&pmid=32378648 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32378648 #FOAvip English Wikipedia <ref>{{Cite pmid|32378648}}</ref> Rapid review for the anti-coronavirus effect of remdesivir #MMPMID32378648 Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther 2020[]; 14 (2): 73-76 PMID32378648show ga The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification. |Adenosine Monophosphate/*analogs & derivatives/therapeutic use[MESH] |Alanine/*analogs & derivatives/therapeutic use[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*drug therapy[MESH] |Drug Evaluation, Preclinical[MESH] |Humans[MESH] |Middle East Respiratory Syndrome Coronavirus/drug effects[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |SARS-CoV-2[MESH]Rapid review for the anti-coronavirus effect of remdesivir (epmc).pdf DeepDyve Pubget Overpricing